SRCM
CHAQ.WS

Sage Rock Capital Management’s Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( CHAQ.WS Stock Holding History

Sage Rock Capital Management’s Portfolio CHAQ.WS Stock Details CHAQ.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-321,300
Closed -$302K – 273
2021
Q1 		$302K Hold
321,300
– – 0.04% 194
2020
Q4 		$318K Buy
+321,300
New +$243K 0.05% 108

Other funds holding CHAQ.WS

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

Sage Rock Capital Management's CHAQ.WS Position: Q2 2021 in Review

Sage Rock Capital Management sold out of Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( (CHAQ.WS) in Q2 2021, closing a stake of 321,300 shares — an estimated $302K sold.

Sage Rock Capital Management first reported a position in CHAQ.WS in Q4 2020 and held it in 2 quarters. The position peaked at $318K in Q4 2020. 21 funds tracked by Wall St. Rank hold CHAQ.WS as of Q2 2021.

  • Sage Rock Capital Management reported no remaining Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position as of Q2 2021 after selling out during the quarter.
  • Sage Rock Capital Management sold 321,300 Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( shares in Q2 2021, an estimated $302K.
  • Sage Rock Capital Management first reported a position in Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( in Q4 2020 and held it in 2 quarters.
  • Sage Rock Capital Management's Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position peaked at $318K in Q4 2020.
  • 21 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( as of Q2 2021.

Based on Sage Rock Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.